Mechanistic role of CXCL5 in cardiovascular disease, diabetes mellitus, and kidney disease

被引:8
|
作者
Chen, Ching [1 ]
Chang, Ting-Ting [1 ,2 ]
Chen, Jaw-Wen [1 ,3 ,4 ,5 ,6 ,7 ,8 ]
机构
[1] Natl Yang Ming Chiao Tung Univ, Dept & Inst Pharmacol, Sch Med, Taipei, Taiwan
[2] Natl Yang Ming Chiao Tung Univ, Biomed Ind PhD Program, Taipei, Taiwan
[3] Taipei Med Univ Hosp, Div Cardiol, Dept Med, Taipei, Taiwan
[4] Taipei Med Univ Hosp, Dept Res, Taipei, Taiwan
[5] Taipei Med Univ Hosp, Cardiovasc Res Ctr, Taipei, Taiwan
[6] Taipei Med Univ, Taipei, Taiwan
[7] Natl Yang Ming Chiao Tung Univ, Cardiovasc Res Ctr, Taipei, Taiwan
[8] Taipei Med Univ Hosp, Dept Res, Taipei, Taiwan
关键词
Chemokine; Cardiovascular disease; Diabetes mellitus; Kidney disease; CXCL5; CHEMOKINE RECEPTORS; PEPTIDE ENA-78; NEUTROPHIL RECRUITMENT; LIGAND; 5; CELLS; EXPRESSION; CYTOKINES; OBESITY; INFLAMMATION; HOMEOSTASIS;
D O I
10.1016/j.lfs.2023.122018
中图分类号
R-3 [医学研究方法]; R3 [基础医学];
学科分类号
1001 ;
摘要
Chemokines, by modulating inflammation process, could contribute to the development of cardiovascular dis-ease, diabetes mellitus (DM), and kidney disease. Chemokine CXC motif ligand 5 (CXCL5) is one of the inducible chemokines that may be involved in various inflammatory diseases. Given the bidirectional promiscuity char-acteristics of the chemokine system, the mechanistic roles of CXCL5 should be further explored in each specific disease. In this article, we sought to review the recent evidence on the differential effects of CXCL5 and their potential mechanisms in cardiovascular disease, DM, and renal disease individually. Future study is still required to verify if CXCL5 could be a novel therapeutic target in these diseases.
引用
收藏
页数:7
相关论文
共 50 条
  • [31] CXCL5 plasma levels decrease in patients with chronic liver disease
    Tacke, Frank
    Zimmermann, Henning W.
    Trautwein, Christian
    Schnabl, Bernd
    JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY, 2011, 26 (03) : 523 - 529
  • [32] CCL7 as a novel inflammatory mediator in cardiovascular disease, diabetes mellitus, and kidney disease
    Ting-Ting Chang
    Ching Chen
    Jaw-Wen Chen
    Cardiovascular Diabetology, 21
  • [33] CCL7 as a novel inflammatory mediator in cardiovascular disease, diabetes mellitus, and kidney disease
    Chang, Ting-Ting
    Chen, Ching
    Chen, Jaw-Wen
    CARDIOVASCULAR DIABETOLOGY, 2022, 21 (01)
  • [34] MicroRNAs and Cardiovascular Disease in Diabetes Mellitus
    Ding, Yue
    Sun, Xue
    Shan, Peng-Fei
    BIOMED RESEARCH INTERNATIONAL, 2017, 2017
  • [35] Epidemiology of diabetes mellitus and cardiovascular disease
    Trout Guardiola, Guillermo
    DUAZARY, 2007, 4 (02) : 84 - 84
  • [36] Pathophysiology of cardiovascular disease in diabetes mellitus
    Rodriguez-Araujo, Gerardo
    Nakagami, Hironori
    CARDIOVASCULAR ENDOCRINOLOGY & METABOLISM, 2018, 7 (01): : 4 - 9
  • [37] Homocysteine and cardiovascular disease in diabetes mellitus
    Jeremy, JY
    Shukla, N
    Angelini, GD
    ATHEROSCLEROSIS, 2002, 164 (02) : 383 - 384
  • [38] Epidemiology of Diabetes Mellitus and Cardiovascular Disease
    Diana Glovaci
    Wenjun Fan
    Nathan D. Wong
    Current Cardiology Reports, 2019, 21
  • [39] Epidemiology of Diabetes Mellitus and Cardiovascular Disease
    Glovaci, Diana
    Fan, Wenjun
    Wong, Nathan D.
    CURRENT CARDIOLOGY REPORTS, 2019, 21 (04)
  • [40] Central and Peripheral Immune Activation in Bipolar Illness: Possible Role of the Chemokine CXCL5 in Disease Pathogenesis
    Quinones, Marlon P.
    Jimenez, Fabio
    Perez-Algorta, Guillermo
    Clark, Kasandra
    Ahuja, Seema S.
    Bowden, Charles L.
    BIOLOGICAL PSYCHIATRY, 2009, 65 (08) : 169S - 169S